In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
AstraZeneca buys Omthera Pharma to bolster its cardiovascular drug business.
Stock futures point to a rebound Tuesday amid expectations of improved economic data and a spike in merger deals.
Stocks are up as AstraZeneca pays millions for Omthera, while Valeant buys Bausch & Lomb and Tiffany's earnings shine.
U.S. stock futures point higher; Valeant agrees to buy Bausch & Lomb; AstraZeneca to buy Omthera; 'Fast & Furious 6' takes in $120 million.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.